<DOC>
	<DOCNO>NCT02397525</DOCNO>
	<brief_summary>Evaluate safety three 8-week course treatment LIPO-202 non-obese patient central abdominal bulging . Efficacy measurement also collect .</brief_summary>
	<brief_title>An Open-Label Study Evaluate Retreatment With LIPO-202</brief_title>
	<detailed_description />
	<criteria>Provided consent Healthy male nonpregnant female subject BMI &lt; 30 kg/m2 Stable diet exercise routine Central abdominal bulging least `` Slight Bulge , Not Flat '' Have treatment fat around abdomen , include surgical procedure ( tummy tuck , liposuction ) , injection fat loss treatment device reduce fat abdomen Plan start weight loss exercise program study . Be woman pregnant , breast feeding , baby within 6 month and/or use appropriate birth control . Known hypersensitivity study drug Prior current enrollment Neothetics ( formerly Lithera ) study involve LIPO102 LIPO202</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>